Biblio
“Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1313-1325, 2018.
, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
, “Relation of Literacy and Music Literacy to Dementia in Older Black and White Brazilians.”, J Alzheimers Dis, vol. 84, no. 2, pp. 737-744, 2021.
, “Relation of a Socioeconomic Index with Cognitive Function and Neuroimaging in Hypertensive Individuals.”, J Alzheimers Dis, vol. 82, no. 2, pp. 815-826, 2021.
, “Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.”, J Alzheimers Dis, vol. 54, no. 2, pp. 801-8, 2016.
, “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
, “Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 2, pp. 533-549, 2018.
, “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
, “Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
, “Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.”, J Alzheimers Dis, vol. 52, no. 2, pp. 403-16, 2016.
, “Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia.”, J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
, “Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.”, Neuron, vol. 74, no. 3, pp. 467-74, 2012.
, “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
, “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
, “Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1385-1405, 2020.
, “Reduced Gray Matter Volume of the Thalamus and Hippocampal Region in Elderly Healthy Adults with no Impact of APOE ɛ4: A Longitudinal Voxel-Based Morphometry Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 757-771, 2018.
, “Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
, “Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
, “Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.”, J Alzheimers Dis, vol. 58, no. 2, pp. 585-595, 2017.
, “Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 919-925, 2017.
, “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
, “Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.”, J Alzheimers Dis, vol. 53, no. 2, pp. 705-12, 2016.
, “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
, “Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 131-139, 2017.
, “Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.”, J Alzheimers Dis, vol. 57, no. 3, pp. 645-665, 2017.
,